A diabetes diagnosis isn’t the same for everyone. While each type of diabetes is characterized by high blood sugar, type 1, type 1.5, and type 2 diabetes have different causes, risk factors, and ...

Type 2 diabetes, linked to insulin resistance, affects a significant portion of the American population, many undiagnosed. Pre-diabetes, also caused by insulin resistance, often progresses to Type 2 ...

Please provide your email address to receive an email when new articles are posted on . Some patients with new-onset diabetes may have symptoms that are indicative of both type 1 and type 2 diabetes.

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...

Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or ...